"CSL and MSB two very worthwhile holdings......cutting edge pipelines, based on respected science...."
I struggle to think of two more different companies [*]
(Nice attempt at a cross-promote, though)
[*] Given their share prices mirror each other, almost exactly, about the x-axis, evidently the market also views them as two very, very different animals.
PS. Imagine going to CLS's Paul Perrault as saying to him, "You know what? Don't you think your company is very much like Mesoblast?"
How far away do you think the laughter will be heard?
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-167
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$308.56 |
Change
1.960(0.64%) |
Mkt cap ! $149.1B |
Open | High | Low | Value | Volume |
$308.93 | $311.00 | $306.28 | $198.7M | 643.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 859 | $308.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$308.65 | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 307.700 |
1 | 17 | 307.600 |
1 | 200 | 307.500 |
1 | 71 | 307.470 |
2 | 914 | 307.300 |
Price($) | Vol. | No. |
---|---|---|
308.650 | 5 | 1 |
308.700 | 60 | 1 |
308.720 | 914 | 1 |
308.730 | 71 | 1 |
308.750 | 100 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online